We are humans revolutionizing the future of healthcare diagnostics through artificial intelligence
“Our peripheral neuropathy screening solution will revolutionize preventative care for diabetic patients.”
— Peter Soliz (PhD)
“We are using AI to improve the diagnosis of malaria and increase the quality of life for children around the world.”
— Vinayak Joshi (PhD)
VisionQuest Biomedical was founded in 2007 with the goal of developing and commercializing advanced technologies aimed at improving care in diabetes.
Through grant funding from the National Institutes of Health and private investment this stated strategic objective is being met, as evidenced in the commercialization of two NIH-funded technologies at clinics screening for diabetic retinopathy.
VisionQuest has developed and successfully deployed a software product for automatic analysis of retinal images in the detection of lesions in patients with diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma.
Our automatic, real-time image quality screening system is also now being used in two commercial retinal cameras to ensure the highest possible retinal image quality, critically important for reading centers to make the best possible determination of a case.
VisionQuest Biomedical Milestones
EyeStar deployed in Mexico
Diabetic Foot testing device development.
Aspire clinical testing in Africa
+25,000 patients tested with Eyestar
Bring Eyestar to USA
VisionQuest's products saving visions and lives Worldwide
Our mission is to develop and deploy image-based technologies to improve access to health care for millions of individuals in the United States and around the world, especially in the fields of diabetes and eye care.
CTO & Founder
Pete is the principal investigator on the NIH grants that funded the development of EyeStar. He continues his mission of developing AI technologies for health care and securing additional non-dilutive funding.
Jeff Wigdahl PhD
Jeff specializes in developing software for retinal image analysis. He has developed software for the detection of retinopathy of prematurity, diabetic retinopathy, and hypertensive retinopathy.
He obtained his master’s degree from the University of New Mexico and his PhD from the University of Padova.
Dean has over 25 years of accounting experience in various industries including health-care R&D, oil and gas, and mining. He has extensive experience in financial reporting and budgeting.
He obtained his bachelor's of business administration from the University of Texas at Arlington.
Sheraz has over 35 years of administrative experience. She handles the duties of clinical coordinator for the i-RxTherm project and provides administrative assistance to VisionQuest’s leadership.
Send us a message, we want to hear from you.